Hyporeactivity of mesenteric resistance arteries in portal hypertensive rats

Journal of Hepatology

Volumn 24, Issue 4, 1996, Pages 487-490

  Sogni, Philippe ^a,b   Sabry, Sana ^b   Moreau, Richard ^a   Gadano, Adrián ^a   Lebrec, Didier ^a   Dinh Xuan, Anh Tuan ^b  

^a BEAUJON HOSPITAL   (France)

^b Université Paris Descartes   (France)

Author keywords

Nitric oxide; Portal hypertension; Prostaglandins; Vascular reactivity

Indexed keywords

NITRIC OXIDE; PROSTAGLANDIN; VASOCONSTRICTOR AGENT;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; IN VITRO STUDY; MESENTERIC ARTERY; NONHUMAN; PORTAL HYPERTENSION; PRIORITY JOURNAL; RAT; REACTION ANALYSIS; RESISTANCE BLOOD VESSEL;

EID: 0029985846     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(96)80170-X     Document Type: Article

References (15)

1. Mahl TC, Groszmann RJ. The pathophysiology of portal hypertension. In: Okuda K, Benhamou JP, eds. Portal Hypertension: Clinical and Physiological Aspects. Tokyo: Springer-Verlag, 1991: 27-35.
2. Vallance P, Moncada S. Hyperdynamic circulation in cirrhosis: a role for nitric oxide? Lancet 1991; 337: 776-8.
3. Pizcueta P, Piqué JM, Fernández M, Bosch J, Rodés J, Whittle BJR, Moncada S. Modulation of the hyperdynamic circulation of cirrhotic rats by nitric oxide inhibition. Gastroenterology 1992; 103: 1909-15.
4. Claria J, Jimenez W, Ross J, Asbert M, Castro A, Arroyo V, Rivera F, Rodés J. Pathogenesis of arterial hypotension in cirrhotic rats with ascites: role of endogenous nitric oxide. Hepatology 1992; 15: 343-9.
5. Oberti F, Sogni P, Cailmail S, Moreau R, Pipy B, Lebrec D. Role of prostacyclin in hemodynamic alterations in conscious rats with extrahepatic or intrahepatic portal hypertension. Hepatology 1993; 18: 621-7.
6. Wu Y, Burns RC, Sitzmann JV. Effects of nitric oxide and cyclooxygenase inhibition on splanchnic hemodynamics in portal hypertension. Hepatology 1993; 18: 1416-21.
7. Castro A, Jimenez W, Claria J, Ros J, Martinez JM, Bosch M, Arroyo V, Piulats J, Rivera F, Rodes J. Impaired responsiveness to Angiotensin II in experimental cirrhosis: role of nitric oxide. Hepatology 1993; 18: 367-72.
8. Gadano A, Sogni P, Yang S, Cailmail S, Gaudin C, Moreau R, Nepveux P, Couturier D, Lebrec D. Evidence for an endothelial calcium-calmodulin dependent nitric oxide synthase in the in vitro vascular hyporeactivity of 7ortal hypertensive rats. Hepatology 1994; 20: 97A.
9. Sieber CC, Lopez Talavera JC, Groszmann RJ. Role of nitric oxide in the in vitro splanchnic vascular hyporeactivity in ascitic cirrhotic rats. Gastroenterology 1993; 104: 1750-4.
10. Benoit JN, Granger DN. Intestinal microvascular adaptation to chronic portal hypertension in the rat. Gastroenterology 1988; 94: 471-6.
11. Mulvany MJ, Aalkjær C. Structure and function of small arteries. Physiol Rev 1990; 70: 921-61.
12. Mulvany MJ, Halpern W. Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ Res 1977; 41: 19-26.
13. Hwa JJ, Gibaudi L, Williams P, Chatterjee M. Comparison of acetylcholine-dependent relaxation in large and small arteries of rat mesenteric vascular bed. Am J Physiol 1994; 266: H952-68.
14. Lebrec D. Animal models of portal hypertension. In: Okuda K, Benhamou JP, eds. Portal Hypertension: Clinical and Physiological Aspects. Tokyo: Springer-Verlag, 1991: 101-13.
15. Cahill PA, Vu YP, Sitzmann JV. Nitric oxide synthase activity in portal hypertension. Hepatology 1993; 18: 141A.